Apolipoprotein E and Atherosclerosis

This publication has 18 references indexed in Scilit:

• Subphysiologic Apolipoprotein E (ApoE) Plasma Levels Inhibit Neointimal Formation After Arterial Injury in ApoE-Deficient Mice
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
• Cellular and Molecular Mechanisms of Atherosclerosis with Mouse Models
  Trends in Cardiovascular Medicine, 2004
• LRP and PDGF Signaling: A Pathway to Atherosclerosis
  Trends in Cardiovascular Medicine, 2004
• Hypomorphic Apolipoprotein E Mice
  Journal of Biological Chemistry, 2002
• Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E
  Journal of Biological Chemistry, 2001
• Hepatic Expression of Apolipoprotein E Inhibits Progression of Atherosclerosis without Reducing Cholesterol Levels in LDL Receptor-Deficient Mice
  Molecular Therapy, 2000
• An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo.
  Journal of Clinical Investigation, 1998
• Apolipoprotein E. Structure, Function, and Possible Roles in Alzheimer's Diseasea
  Annals of the New York Academy of Sciences, 1996
• Uses and limitations of high dose dipyridamole stress echocardiography for evaluation of coronary artery disease.
  Heart, 1992
• Apolipoprotein E polymorphism and atherosclerosis.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988